Biomerica (BMRA) Amortization of Deferred Charges (2021 - 2026)
Biomerica (BMRA) posted Amortization of Deferred Charges of $85000.0 for Q1 2026, up 2.41% sequentially from $83000.0 in Q4 2025, and up 8.97% YoY from $78000.0 in Q1 2025.
Biomerica (BMRA) Amortization of Deferred Charges (2021 - 2026) Analysis & Trends
Biomerica has reported Amortization of Deferred Charges for 6 years, with the latest figure at $85000.0 in Q1 2026.
- Quarterly Amortization of Deferred Charges rose 8.97% year-over-year to $85000.0 in Q1 2026, while the trailing twelve-month figure through Feb 2026 was $331000.0 (up 7.82% YoY) and the FY2025 annual result came in at $313000.0, up 6.83% from the prior year.
- Amortization of Deferred Charges grew to $85000.0 in Q1 2026 per BMRA's latest filing, from $83000.0 in the prior quarter.
- Over five years, Amortization of Deferred Charges peaked at $85000.0 in Q1 2026 and troughed at $63657.0 in Q1 2022.
- A 5-year average of $73703.6 and a median of $74000.0 in 2024 frame the typical range for Amortization of Deferred Charges.
- The sharpest annual moves came in 2023 and 2024: Amortization of Deferred Charges declined 1.97% in 2023, then gained 15.38% in 2024.
- Over 5 years, Amortization of Deferred Charges stood at $67000.0 in 2022, then increased by 8.96% to $73000.0 in 2023, then climbed by 6.85% to $78000.0 in 2024, then rose by 6.41% to $83000.0 in 2025, then increased by 2.41% to $85000.0 in 2026.
- According to Business Quant data, Amortization of Deferred Charges over the past three periods registered $85000.0, $83000.0, and $82000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn |
| 10 | Biomerica | 4.85 Mn | 3.51 Mn | -44,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 85,000.00 |
| Feb 28, 2026 | 85,000.00 |
| Nov 30, 2025 | 83,000.00 |
| Nov 30, 2025 | 83,000.00 |
| Aug 31, 2025 | 82,000.00 |
| Aug 31, 2025 | 82,000.00 |
| May 31, 2025 | 81,000.00 |
| May 31, 2025 | 81,000.00 |
| Feb 28, 2025 | 78,000.00 |
| Feb 28, 2025 | 78,000.00 |
| Nov 30, 2024 | 78,000.00 |
| Nov 30, 2024 | 78,000.00 |
| Aug 31, 2024 | 76,000.00 |
| Aug 31, 2024 | 76,000.00 |
| May 31, 2024 | 75,000.00 |
| May 31, 2024 | 75,000.00 |
| Feb 29, 2024 | 74,000.00 |
| Feb 29, 2024 | 74,000.00 |
| Nov 30, 2023 | 73,000.00 |
| Nov 30, 2023 | 73,000.00 |